Efficacy of nedocromil 2% versus fluorometholone 0.1%: a randomised, double masked trial comparing the effects on severe vernal keratoconjunctivitis
- aDepartment of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia, bThe Eye Center, Riyadh, Saudi Arabia
- Professor Khalid F Tabbara, PO Box 55307, Riyadh 11534, Saudi Arabia.
- Accepted 26 August 1998
Abstract
AIMS To compare the efficacy of topical nedocromil 2% with fluorometholone 0.1% in vernal keratoconjunctivitis (VKC).
METHODS In a double masked random design, 24 patients with severe vernal keratoconjunctivitis were placed at random on nedocromil 2% eye drops in one eye and fluorometholone 0.1% in the fellow eye. At the end of the 2 week treatment period, the patient crossed over the eye drops (if asymptomatic in one eye), or continued with nedocromil sodium in both eyes (if asymptomatic in both eyes). All patients were examined weekly and ocular surface temperature recorded for a period of 6 weeks.
RESULTS Improvement in the watering, discharge, conjunctival hyperaemia, papillary hypertrophy, and Trantas’ dots was noted in both groups, but overall fluorometholone was significantly more effective than nedocromil. Eyes treated with fluorometholone showed a significant decrease in ocular surface temperature compared with nedocromil treated eyes (p = 0.03).
CONCLUSIONS Both nedocromil and fluorometholone were effective in ameliorating the signs and symptoms of vernal keratoconjunctivitis. No adverse effects were noted in the nedocromil group.
